שווי פירמה כולל: NanoVibronix Inc. (NAOV)

NanoVibronix, Inc. (NAOV) medical patch production relies on the automated assembly of piezo elements to ensure assembly precision. However, prolonged insurance reimbursement approvals in the US and a persistent capital deficit create financial challenges, with the Enterprise Value standing at -1.44. The company's price action available on the GURU.Markets chart highlights the potential for expanding the customer base by introducing ultrasonic systems into urology and surgery.

The ability of NanoVibronix, Inc. (NAOV) to withstand the conservatism of the therapeutic ultrasound market and the slow insurance approval process for procedures directly impacts the investment attractiveness of its assets. Analyzing the current enterprise value, an investor can determine the actual acquisition cost of the business, calculated as the sum of market capitalization and net debt minus cash, which allows for an objective assessment of the risk of overpayment amid a prolonged recovery.